Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

EctoShed: a novel gene delivery platform for functional analysis of adipocyte-shed proteoforms

Tavanez AR., Egedal NM., Stanic N., Topel H., Kornfeld JW.

Animal Study, published in BMC Res Notes (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
BMC Res Notes (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42093046
PMCID
PMC13151326
DOI
10.1186/s13104-026-07680-2

Abstract (original English)

Objective The proteolytic cleavage of membrane-bound proteins, ectodomain shedding, functionally expands the reservoir of proteins/peptides available for endocrine crosstalk, and metabolic regulation. However, the functional understanding of secreted proteoforms, including whether they act synergistically or antagonistically with their membrane precursors, is often unknown. We aimed to develop a novel viral vector-based gene delivery platform enabling characterization of both membrane-bound and soluble proteoforms in adipocytes, independent of endogenous shedding. To this end, we elected amine oxidase copper-containing 3 (AOC3) as a target for validation. Results We describe a novel platform, termed 'EctoShed', achieving adipocyte-specific expression of different proteoforms of AOC3 - full-length and membrane-bound or a soluble AOC3 mimic (m-sAOC3) - by capitalising on the established lentiviral and adeno-associated virus gene delivery systems. In vitro transduction of primary white adipocytes induced significant expression of both isoforms, whilst retaining AOC3 enzymatic activity. In vivo delivery to inguinal white adipose tissue enabled depot-specific AOC3 expression and increased abundance of m-sAOC3 in serum. Mice expressing m-sAOC3 exhibited reduced fat mass and fasting glucose levels. Thus, EctoShed is a novel tool to dissect the functional roles of soluble proteoforms s

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAnimalsMice, Inbred C57BLHumansMiceDependovirusLentivirusGene Transfer TechniquesTransduction, GeneticGenetic Vectors

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.